Lv1
20 积分 2024-07-10 加入
Pirfenidone and risk of lung cancer development in IPF: a nationwide population-based study
1天前
待确认
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis
1天前
已完结
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
7天前
已完结
Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis
8天前
已完结
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small cell lung cancer
12天前
已完结
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
27天前
已完结
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
1个月前
已完结
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
2个月前
已完结
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC
2个月前
已完结
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
2个月前
已完结
皖公网安备34019202002308
